Synopsis
Synopsis
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
2. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2h-pyran-3,4,5-triol
3. Bms 512148
4. Bms-512148
5. Bms512148
6. Dapagliflozin
7. Farxiga
8. Forxiga
1. 960404-48-2
2. Dapagliflozin Propanediol Monohydrate
3. Dapagliflozin Propanediol Hydrate
4. Farxiga
5. Dapagliflozin ((2s)-1,2-propanediol, Hydrate)
6. Bms-512148-05
7. Dapagliflozin S-propylene Glycol Monohydrate
8. Dapagliflozin Propylene Glycolate Hydrate
9. Chebi:85079
10. Dapagliflozin Propanediol [usan]
11. Dapagliflozin Mixture With Propylene Glycol, Hydrate
12. 887k2391vh
13. (2s,3r,4r,5s,6r)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;(2s)-propane-1,2-diol;hydrate
14. Dapagliflozin [usan:inn]
15. Dapagliflozin Propylene Glycol Hydrate
16. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol Compound With (s)-propane-1,2-diol (1:1) Hydrate
17. D-glucitol, 1,5-anhydro-1-c-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1s)-, Compd. With (2s)-1,2-propanediol, Hydrate (1:1:1)
18. Unii-887k2391vh
19. Dapagliflozin Propylene Glycolate Hydrate [jan]
20. Dapagliflozin (s)-propylene Glycol Hydrate
21. Chembl2103802
22. Dtxsid00914678
23. Ex-a2824
24. Dapagliflozin Propylene Glycol
25. Hy-10450a
26. Mfcd28167768
27. S5566
28. Akos027250601
29. Ccg-269711
30. Ac-29230
31. As-64915
32. Dapagliflozin (2s)-1,2-propanediol Hydrate
33. F20667
34. Bms-512148 (2s)-1,2-propanediol, Hydrate
35. Dapagliflozin (2s)-1,2-propanediol Monohydrate
36. Xigduo Component Dapagliflozin Propanediol
37. A900162
38. Dapagliflozin Propanediol Component Of Xigduo
39. Dapagliflozin Propanediol Monohydrate [who-dd]
40. Q27158320
41. Dapagliflozin Propanediol Monohydrate [ema Epar]
42. Dapagliflozin Compound With (2s)-1,2-propanediol Hydrate
43. Dapagliflozin Compound With (2s)-1,2-propanediol Hydrate [mi]
44. (2s)-propane-1,2-diol (2s,3r,4r,5s,6r)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol Hydrate
45. (2s)-propane-1,2-diol--(1s)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-d-glucitol--water (1/1/1)
46. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro- 2h-pyran-3,4,5-triol, (2s)-propane-1,2-diol (1:1) Monohydrate
47. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol (s)-propane-1,2-diol Hydrate
48. (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol, (2s)-propane-1,2-diol (1:1) Monohydrate
49. 1700615-13-9
| Molecular Weight | 503.0 g/mol |
|---|---|
| Molecular Formula | C24H35ClO9 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 502.1969604 g/mol |
| Monoisotopic Mass | 502.1969604 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 493 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Forxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance.
- in addition to other medicinal products for the treatment of type 2 diabetes.
For study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied.
Heart failure
- Forxiga is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction.
Chronic kidney disease
- Forxiga is indicated in adults for the treatment of chronic kidney disease.
Type 2 diabetes mellitus
Edistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance.
- in addition to other medicinal products for the treatment of type 2 diabetes.
For study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 and 5. 1.
Heart failure
Edistride is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction.
Chronic kidney disease
Edistride is indicated in adults for the treatment of chronic kidney disease.
Sodium-Glucose Transporter 2 Inhibitors
Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)
A10BK01
A10BK01
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm : Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District -532409, Andhr...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Dapagliflozin Propanediol Monohydrate IHS
Date of Issue : 2024-04-03
Valid Till : 2027-01-21
Written Confirmation Number : WC-0493
Address of the Firm : Unit-IV, Plot No: 34B, 40B & 60B, J.N. Pharma City, Thanam (V), Parawada (M), An...
Date of Issue : 2025-06-16
Valid Till : 2028-06-16
Written Confirmation Number : WC-0036
Address of the Firm : (Unit-l), Sy.No.291, 346P, 347, 348P, 473, 474, 490/2, Veerabhadraswamy Temple R...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Dapagliflozin Propanediol Monohydrate IH
Date of Issue : 2025-09-18
Valid Till : 2028-07-02
Written Confirmation Number : WC-0195
Address of the Firm : Plot No. 3102/B, GIDC Estate Ankleshwar, Bharuch-393002, Gujarat, India
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Dapagliflozin Propanediol Monohydrate IH
Date of Issue : 2025-09-03
Valid Till : 2028-09-02
Written Confirmation Number : WC-0362
Address of the Firm : Plot No:4, Hetero Infrastructure SEZ Ltd.,Narasapuram, Visakhapatnam-531081, And...
Date of Issue : 2025-12-24
Valid Till : 2028-08-04
Written Confirmation Number : WC-0038
Address of the Firm : Plot no. 213-215 & 216/B, IDA Phase II, Pashamylaram, Sangareddy (District), Tel...

Dapagliflozin Propanediol Monohydrate IH
Date of Issue : 2022-06-14
Valid Till : 2025-07-02
Written Confirmation Number : WC-0094nA2A
Address of the Firm : Plot No. 72 & 82/A, KIADB Industrial Area, Jigani, Anekal Taluk, Bengaluru-560 1...

Dapagliflozin Propanediol Monohydrate IH
Date of Issue : 2022-08-31
Valid Till : 2025-07-14
Written Confirmation Number : WC-0090
Address of the Firm : MIs Kopran Research Laboratories Limited, K-4/4, Additional MIDC, Birwadi, Mahad...

Date of Issue : 2022-08-31
Valid Till : 2025-07-14
Written Confirmation Number : WC-0090
Address of the Firm : MIs Kopran Research Laboratories Limited, K-4/4, Additional MIDC, Birwadi, Mahad...

Dapagliflozin Propanediol Monohydrate IH/USP
Date of Issue : 2025-06-05
Valid Till : 2028-07-02
Written Confirmation Number : WC-0060
Address of the Firm : Village- Masulkhana, Parwanoo, Distt. Solan, Himachal Pradesh, India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Dapagliflozin propanediol hydrate
Registrant Name : Seongwoo Chemical Co., Ltd.
Registration Date : 2026-03-24
Registration Number : Su 574-16-ND(2)
Manufacturer Name : Dr. Reddy's Laboratories Lim...
Manufacturer Address : CTO-SEZ Process Unit-01, Sector No.'s 28 to 34, 36 to 37, 40, 50 to 53 & 03, Survey N...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Dapagliflozin propanediol hydrate
Registrant Name : Pamire Co., Ltd.
Registration Date : 2020-08-25
Registration Number : Su574-16-ND
Manufacturer Name : Dr. Reddy's Laboratories Lim...
Manufacturer Address : CTO-SEZ Process Unit-01, Sector No's. 28 to 34, 36 to 37, 40, 50 to 53 & 03 Survey No...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Dapagliflozin propanediol hydrate
Registrant Name : Poonglim Pharmaceutical Co., Ltd.
Registration Date : 2022-11-24
Registration Number : Su574-16-ND(1)
Manufacturer Name : Dr. Reddy's Laboratories Lim...
Manufacturer Address : CTO-SEZ Process Unit-01, Sector No's. 28 to 34, 36 to 37, 40, 50 to 53 & 03 Survey No...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Dapagliflozin propanediol hydrate
Registrant Name : Seongwoo Chemical Co., Ltd.
Registration Date : 2025-05-19
Registration Number : Su473-32-ND
Manufacturer Name : Metrochem API Pvt Ltd, Unit-...
Manufacturer Address : Plot No. 34B, 40B & 60B, JN Pharma City, Thanam (V) Parawada (M), Anakapalli District...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Dapagliflozin propanediol hydrate
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-10-13
Registration Number : Su434-24-ND
Manufacturer Name : Cohance Lifesciences Limited...
Manufacturer Address : Plot No. - 3102/B, GIDC, City – Ankleshwar - 393 002, Dist. - Bharuch, Gujarat Stat...
Dapagliflozin propanediol hydrate
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2024-10-28
Registration Number : Su434-68-ND
Manufacturer Name : Ami Lifesciences Pvt. Ltd.
Manufacturer Address : Block No. 82/B, ECP Road, At & Post. Karakhadi-391 450, Taluka:Padra, Dist.Vadodara, ...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Dapagliflozin propanediol hydrate
Registrant Name : Wonpung Pharmaceutical Co., Ltd.
Registration Date : 2024-04-03
Registration Number : Su21-9-ND(7)
Manufacturer Name : Honour Lab Limited
Manufacturer Address : Unit-III, Plot No.4, Hetero Infrastructure SEZ Ltd, N. Narasapuram Village, Nakkapall...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Dapagliflozin propanediol hydrate
Registrant Name : Seongwoo Chemical Co., Ltd.
Registration Date : 2026-03-10
Registration Number : Number 21-9-ND(8)
Manufacturer Name : Honour Lab Limited
Manufacturer Address : Unit-III, Plot No.4, Hetero Infrastructure SEZ Ltd, N. Narasapuram Village, Nakkapall...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Dapagliflozin propanediol hydrate
Registrant Name : Huseong Bio Co., Ltd.
Registration Date : 2023-08-22
Registration Number : Su21-9-ND(6)
Manufacturer Name : Honour Lab Limited(Unit-III)
Manufacturer Address : Unit-III, Plot No.4, Hetero Infrastructure SEZ Ltd, N. Narasapuram Village, Nakkapall...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
Dapagliflozin propanediol hydrate
Registrant Name : Jeil Pharmaceutical Co., Ltd.
Registration Date : 2023-07-28
Registration Number : Su21-9-ND(5)
Manufacturer Name : Honour Lab Limited
Manufacturer Address : Unit-III, Plot No.4, Hetero Infrastructure SEZ Ltd, N. Narasapuram Village, Nakkapall...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-006
Start Marketing Date : 2018-08-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-030
Start Marketing Date : 2019-08-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-037
Start Marketing Date : 2021-06-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1014
Start Marketing Date : 2019-07-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
NDC Package Code : 69037-0038
Start Marketing Date : 2014-01-08
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54864-673
Start Marketing Date : 2014-01-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 54864-668
Start Marketing Date : 2022-06-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 71901-607
Start Marketing Date : 2021-11-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 66651-924
Start Marketing Date : 2019-12-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14501-0091
Start Marketing Date : 2014-03-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.
Dapagliflozin Propanediol Monohydrate
About the Company : Polpharma API, a division of a leading Polish pharmaceutical group, has over 75 years of expertise in process development and cGMP manufacturing. Based at an FDA-approved site in C...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Dapagliflozin Propanediol Monohydrate
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Dapagliflozin Propanediol Monohydrate
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress
About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in API and advanced intermediate R&D and manufacturing, delivering comprehensive CDMO/CRO/OEM services and Finished ...
About the Company : Neuland Laboratories, established in 1984 and headquartered in Hyderabad, is a publicly listed company offering solutions for pharmaceutical chemistry needs—from library compound...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Dapagliflozin Propanediol Monohydrate
About the Company : Cohance Lifesciences is a leading CDMO and API platform delivering products and services across the full molecule lifecycle, from development to commercialization. With strong expe...
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
About the Company : Egis, part of the Servier Group, manufactures products at three EMA-, FDA-, ANVISA-, PMDA-, and KFDA-certified sites in Hungary. It sells branded products in 18 countries and reach...
Dapagliflozin Propanediol Monohydrate
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
About the Company : Ami Lifesciences, established in 2006, is a rapidly growing API manufacturing company in India with strong capabilities in cardiovascular, anti-diabetic, CNS, and respiratory thera...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Dapagliflozin Propanediol Monohydrate
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Forxiga (Dapagliflozin Propanediol) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Myocardial Infarction.
Lead Product(s): Dapagliflozin Propanediol Monohydrate,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Forxiga
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: AstraZeneca
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 10, 2023

Lead Product(s) : Dapagliflozin Propanediol Monohydrate,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : AstraZeneca
Deal Size : Inapplicable
Deal Type : Inapplicable
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
Details : Forxiga (Dapagliflozin Propanediol) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Myocardial Infarction.
Product Name : Forxiga
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 10, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Dapagliflozin, metformin and glimepiride fixed dose combination is approved for the treatment of patients with type 2 diabetes.
Lead Product(s): Glimepiride,Dapagliflozin Propanediol Monohydrate,Metformin
Therapeutic Area: Endocrinology Brand Name: Gemer Dapa
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 24, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Glimepiride,Dapagliflozin Propanediol Monohydrate,Metformin
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Sun Pharma Dapagliflozin Glimepiride Metformin FDC gets CDSCO Panel Nod for Phase 3 Trial
Details : Dapagliflozin, metformin and glimepiride fixed dose combination is approved for the treatment of patients with type 2 diabetes.
Product Name : Gemer Dapa
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 24, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
AstraZeneca India has granted rights to Sun Pharma to promote and distribute Dapagliflozin under the brand name Oxra. Sun Pharma also gained the rights to promote and distribute the Oxramet (Dapagliflozin + Metformin) and Oxraduo (Dapagliflozin + Saxagliptin).
Lead Product(s): Dapagliflozin Propanediol Monohydrate,Inapplicable
Therapeutic Area: Endocrinology Brand Name: Oxra
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Sun Pharmaceutical Industries Limited
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition May 28, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dapagliflozin Propanediol Monohydrate,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Sun Pharmaceutical Industries Limited
Deal Size : Undisclosed
Deal Type : Acquisition
Sun Pharma Acquires Rights to Trademarks of Three Diabetes Drug Brands in India from AstraZeneca
Details : AstraZeneca India has granted rights to Sun Pharma to promote and distribute Dapagliflozin under the brand name Oxra. Sun Pharma also gained the rights to promote and distribute the Oxramet (Dapagliflozin + Metformin) and Oxraduo (Dapagliflozin + Saxagli...
Product Name : Oxra
Product Type : Miscellaneous
Upfront Cash : Undisclosed
May 28, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
After termination of the agreement, AstraZeneca India will continue to independently market Dapagliflozin, the combinations of Dapagliflozin and Metformin as well as Dapagliflozin and Saxagliptin in India under the brand names Forxiga, Xigduo and Qtern respectively.
Lead Product(s): Dapagliflozin Propanediol Monohydrate,Metformin
Therapeutic Area: Endocrinology Brand Name: Xigduo
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: AstraZeneca
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Termination May 28, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dapagliflozin Propanediol Monohydrate,Metformin
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : AstraZeneca
Deal Size : Undisclosed
Deal Type : Termination
AstraZeneca Pharma, Abbott Healthcare Terminate Distribution Agreements for Diabetes Drug in India
Details : After termination of the agreement, AstraZeneca India will continue to independently market Dapagliflozin, the combinations of Dapagliflozin and Metformin as well as Dapagliflozin and Saxagliptin in India under the brand names Forxiga, Xigduo and Qtern r...
Product Name : Xigduo
Product Type : Miscellaneous
Upfront Cash : Undisclosed
May 28, 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
42
PharmaCompass offers a list of Dapagliflozin Propanediol Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dapagliflozin Propanediol Monohydrate manufacturer or Dapagliflozin Propanediol Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dapagliflozin Propanediol Monohydrate manufacturer or Dapagliflozin Propanediol Monohydrate supplier.
PharmaCompass also assists you with knowing the Dapagliflozin Propanediol Monohydrate API Price utilized in the formulation of products. Dapagliflozin Propanediol Monohydrate API Price is not always fixed or binding as the Dapagliflozin Propanediol Monohydrate Price is obtained through a variety of data sources. The Dapagliflozin Propanediol Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A dapagliflozin (S)-propylene glycol hydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of dapagliflozin (S)-propylene glycol hydrate, including repackagers and relabelers. The FDA regulates dapagliflozin (S)-propylene glycol hydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. dapagliflozin (S)-propylene glycol hydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A dapagliflozin (S)-propylene glycol hydrate supplier is an individual or a company that provides dapagliflozin (S)-propylene glycol hydrate active pharmaceutical ingredient (API) or dapagliflozin (S)-propylene glycol hydrate finished formulations upon request. The dapagliflozin (S)-propylene glycol hydrate suppliers may include dapagliflozin (S)-propylene glycol hydrate API manufacturers, exporters, distributors and traders.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A dapagliflozin (S)-propylene glycol hydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of dapagliflozin (S)-propylene glycol hydrate active pharmaceutical ingredient (API) in detail. Different forms of dapagliflozin (S)-propylene glycol hydrate DMFs exist exist since differing nations have different regulations, such as dapagliflozin (S)-propylene glycol hydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A dapagliflozin (S)-propylene glycol hydrate DMF submitted to regulatory agencies in the US is known as a USDMF. dapagliflozin (S)-propylene glycol hydrate USDMF includes data on dapagliflozin (S)-propylene glycol hydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The dapagliflozin (S)-propylene glycol hydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a dapagliflozin (S)-propylene glycol hydrate Drug Master File in Korea (dapagliflozin (S)-propylene glycol hydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of dapagliflozin (S)-propylene glycol hydrate. The MFDS reviews the dapagliflozin (S)-propylene glycol hydrate KDMF as part of the drug registration process and uses the information provided in the dapagliflozin (S)-propylene glycol hydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a dapagliflozin (S)-propylene glycol hydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their dapagliflozin (S)-propylene glycol hydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with KDMF on PharmaCompass.
A dapagliflozin (S)-propylene glycol hydrate CEP of the European Pharmacopoeia monograph is often referred to as a dapagliflozin (S)-propylene glycol hydrate Certificate of Suitability (COS). The purpose of a dapagliflozin (S)-propylene glycol hydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of dapagliflozin (S)-propylene glycol hydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of dapagliflozin (S)-propylene glycol hydrate to their clients by showing that a dapagliflozin (S)-propylene glycol hydrate CEP has been issued for it. The manufacturer submits a dapagliflozin (S)-propylene glycol hydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a dapagliflozin (S)-propylene glycol hydrate CEP holder for the record. Additionally, the data presented in the dapagliflozin (S)-propylene glycol hydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the dapagliflozin (S)-propylene glycol hydrate DMF.
A dapagliflozin (S)-propylene glycol hydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. dapagliflozin (S)-propylene glycol hydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with CEP (COS) on PharmaCompass.
A dapagliflozin (S)-propylene glycol hydrate written confirmation (dapagliflozin (S)-propylene glycol hydrate WC) is an official document issued by a regulatory agency to a dapagliflozin (S)-propylene glycol hydrate manufacturer, verifying that the manufacturing facility of a dapagliflozin (S)-propylene glycol hydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting dapagliflozin (S)-propylene glycol hydrate APIs or dapagliflozin (S)-propylene glycol hydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a dapagliflozin (S)-propylene glycol hydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing dapagliflozin (S)-propylene glycol hydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for dapagliflozin (S)-propylene glycol hydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture dapagliflozin (S)-propylene glycol hydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain dapagliflozin (S)-propylene glycol hydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a dapagliflozin (S)-propylene glycol hydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of dapagliflozin (S)-propylene glycol hydrate suppliers with NDC on PharmaCompass.
dapagliflozin (S)-propylene glycol hydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of dapagliflozin (S)-propylene glycol hydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right dapagliflozin (S)-propylene glycol hydrate GMP manufacturer or dapagliflozin (S)-propylene glycol hydrate GMP API supplier for your needs.
A dapagliflozin (S)-propylene glycol hydrate CoA (Certificate of Analysis) is a formal document that attests to dapagliflozin (S)-propylene glycol hydrate's compliance with dapagliflozin (S)-propylene glycol hydrate specifications and serves as a tool for batch-level quality control.
dapagliflozin (S)-propylene glycol hydrate CoA mostly includes findings from lab analyses of a specific batch. For each dapagliflozin (S)-propylene glycol hydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
dapagliflozin (S)-propylene glycol hydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (dapagliflozin (S)-propylene glycol hydrate EP), dapagliflozin (S)-propylene glycol hydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (dapagliflozin (S)-propylene glycol hydrate USP).